Articles From: Teradata Announces 2013 Fourth Quarter Earnings Release Date to U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma


2014/1/13
Earnings conference call to begin at 8:30 a.m. ET on February 6, 2014 ATLANTA , Jan.
Sign-up for Teradata Announces 2013 Fourth Quarter Earnings Release Date investment picks
2014/1/13
TESSCO Technologies Incorporated (Nasdaq:TESS), a leading provider of the product and value chain solutions required to build, use and maintain wireless systems, will report financial results for its third fiscal quarter ended December 29, 2013 after the market closes on Thursday, January 23, 2014.
Sign-up for TESSCO Technologies Schedules Third-Quarter Fiscal 2014 Earnings Release and Conference Call investment picks
2014/1/13
NEW YORK, Jan.
Sign-up for TG Therapeutics, Inc. to Present at the 32nd Annual J.P. Morgan Healthcare Conference investment picks
2014/1/13
The Alexander Firm P.C., A Professional Law Corporation, announces that it is investigating potential claims against the Board of Directors of American Pacific Corporation (“American Pacific” or the “Company”) (NASDAQ:APFC) related to the proposed acquisition of the Company by H.I.G. Capital, LLC (“HIG”). The transaction is valued at approximately $392 million, or $46.50 per share.
Sign-up for The Alexander Firm P.C. Announces Investigation of American Pacific Corporation investment picks
2014/1/13
The Alexander Firm P.C., A Professional Law Corporation, announces that it is investigating potential claims for breach of fiduciary duty against the Board of Directors of Patient Safety Technologies, Inc. (“Patient Safety” or the “Company”) (OTC:PSTX) concerning the proposed acquisition of the Company by Stryker Corporation (“Stryker”). The transaction is valued at approximately $120 million or $2.22 per share.
Sign-up for The Alexander Firm P.C. Announces Investigation of Patient Safety Technologies, Inc. investment picks
2014/1/13
The Dolan Company (NYSE: DM) announced today that it entered into the Seventh Amendment to its Third Amended and Restated Credit Agreement dated December 6, 2010.
Sign-up for The Dolan Company Amends Its Credit Agreement investment picks
2014/1/13
The Marketing Alliance, Inc. (OTC:MAAL) (“TMA”), today announced financial results for its fiscal 2014 second quarter and six months ended September 30, 2013.
Sign-up for The Marketing Alliance Announces Financial Results for Its Fiscal 2014 Second Quarter and Six Months Ended September 30, 2013 investment picks
2014/1/13
By Steve Goldstein, MarketWatch WASHINGTON (MarketWatch) -- There have been Merger Mondays before, but usually not when the Dow industrials tumble 179 points.
Sign-up for The oddity of a Merger Monday when the market melts investment picks
2014/1/13
http://media.marketwire.com/attachments/201401/TN-214898_expo21.jpg http://media.marketwire.com/attachments/201310/67761_VenetianPalazzoLogo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1080816&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for The Venetian and The Palazzo Las Vegas Ranked Number 3 Meeting Hotel in the United States investment picks
2014/1/13
COMPANY ANNOUNCES $275 MILLION SHARE REPURCHASE PROGRAM, EXPECTS TO LAUNCH "DUTCH AUCTION" TENDER ON JAN.
Sign-up for The Wendy's Company Reports Preliminary 2013 Results, Issues 2014 Outlook And Reaffirms Long-Term Outlook investment picks
2014/1/13
By Annie Gasparro H.J. Heinz Co.
Sign-up for Three More Longtime Executives Leaving Heinz investment picks
2014/1/13
Time Warner Cable Inc. (NYSE:TWC) said today that its Board of Directors has unanimously rejected a third grossly inadequate proposal from Charter Communications (NASDAQ: CHTR) to acquire TWC.
Sign-up for Time Warner Cable Board of Directors Unanimously Rejects Third Grossly Inadequate Proposal from Charter Communications investment picks
2014/1/13
Rigrodsky & Long, P.A.: Do you own shares of Time Warner Cable Inc. (NYSE: TWC )? Did you purchase any of your shares prior to January 13, 2014?
Sign-up for TIME WARNER CABLE INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout Proposal investment picks
2014/1/13
http://media.marketwire.com/attachments/201206/53265_TiVo_logo_2011_thumb.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1081303&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for TiVo to Present at Barclays Select Series 2014: Emerging Cable Technologies Forum investment picks
2014/1/13
TEL AVIV, Israel and COLOGNE, Germany, Jan.
Sign-up for Top Image Systems Signs Six Figure Win at Austrian Oil and Gas Company investment picks
2014/1/13
AMSTERDAM, The Netherlands, Jan.
Sign-up for Tornier Announces Preliminary Fourth Quarter and Full Year 2013 Revenue investment picks
2014/1/13
TowerJazz , the global specialty foundry leader, and MAPS Inc. (Mixed Analog Power Solution), a provider of mobile, lighting and automotive ICs, today announced collaboration on the launch of the first resonant wireless power transfer (WPT) receiver Chip(Rx) for mobile products which integrates high efficiency full active rectifier (FAR) technology and enables wireless charging at a distance which is cutting-edge in the market.
Sign-up for TowerJazz and MAPS Launch First Resonant Wireless Power Transfer (Rx Chip) for Mobile Devices; New Paradigm Enables Charging at Much Greater Distances investment picks
2014/1/13
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0921334001&sourceType=1 http://www.ccnmatthews.com/logos2/transcanada2.jpg CALGARY, ALBERTA --
Sign-up for TransCanada Announces Increased Preferred Share Issue investment picks
2014/1/13
TransEnterix, Inc. (OTCBB: TRXC), a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced that multiple surgeons have used SurgiBot, the company’s patient-side minimally invasive robotic system, to successfully complete general surgery procedures in the porcine model.
Sign-up for TransEnterix Enters Next Phase of Development of SurgiBot™ System investment picks
2014/1/13
By Barry Wood For the first time in a decade there is optimism in Detroit.
Sign-up for Transition time in the rebounding U.S. auto industry investment picks
2014/1/13
http://media.marketwire.com/attachments/201203/23689_Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1081147&ProfileId=051205&sourceType=1 BOCA RATON, FL --
Sign-up for True2Bid Update; Site Will Be Transformed investment picks
2014/1/13
GLENVILLE, N.Y., Jan.
Sign-up for TrustCo to Release Fourth Quarter Results on January 21, 2014; Conference Call on January 22, 2014 investment picks
2014/1/13
TSX Delisting Review - Sunwah International Limited (Symbol: SWH) Canada NewsWire TORONTO , Jan.
Sign-up for TSX Delisting Review - Sunwah International Limited (Symbol: SWH) investment picks
2014/1/13
http://media.marketwire.com/attachments/201205/45834_turn.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1080937&ProfileId=051205&sourceType=1 REDWOOD CITY, CA --
Sign-up for Turn Raises $80 Million Series E Round investment picks
2014/1/13
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0921534001&sourceType=1 http://media3.marketwire.com/logos/20120802-trq200.jpg VANCOUVER, BRITISH COLUMBIA --
Sign-up for Turquoise Hill Closes Successful Rights Offering investment picks
2014/1/13
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1081399&ProfileId=051205&sourceType=1 HENDERSON, NV --
Sign-up for U-Swirl, Inc. to Report Third Quarter Operating Results on January 21, 2014 investment picks
2014/1/13
U.S. Army Awards BLACKHAWK! SERPA with $24 Million Contract BLACKHAWK! SERPA Chosen by U.S. ARMY for Improved Modular Tactical Holster Program ARLINGTON, Va.
Sign-up for U.S. Army Chooses BLACKHAWK!® SERPA® Tactical Holster System investment picks
2014/1/13
By Stephanie Gleason and Joseph Checkler U.S. Bankruptcy Court Judge Burton R.
Sign-up for U.S. Bankruptcy Court Judge Burton R. Lifland Dies investment picks
2014/1/13
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for idelalisib, a targeted, oral inhibitor of PI3K delta, for the treatment of refractory indolent non-Hodgkin’s lymphoma (iNHL). FDA has granted a standard review for the iNHL NDA and has set a target review date under the Prescription Drug User Fee Act (PDUFA) of September 11, 2014.
Sign-up for U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Teradata Announces 2013 Fourth Quarter Earnings Release Date to U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity